1. 2190 Discovery of new molecular subtypes of non-hypermutated metastatic colorectal cancer (mCRC) through a next-generation sequencing (NGS) approach. (September 2015) Authors: Pietrantonio, F.; Perrone, F.; Cremolini, C.; Orlandi, A.; Niger, M.; Caporale, M.; Berenato, R.; Antoniotti, C.; Loupakis, F.; Tamborini, E.; Milione, M.; Settanni, G.; Busico, A.; De Braud, F.; Di Bartolomeo, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2643 Neoadjuvant sorafenib, gemcitabine, and cisplatin (SGC) for muscle-invasive urothelial bladder cancer (UBC): Updated clinical and translational findings of an open-label, single group, phase 2 study. (September 2015) Authors: Necchi, A.; Giannatempo, P.; Mariani, L.; Raggi, D.; Nicolai, N.; Piva, L.; Biasoni, D.; Catanzaro, M.; Torelli, T.; Stagni, S.; Calareso, G.; Togliardi, E.; Colecchia, M.; Busico, A.; Perrone, F.; Pelosi, G.; Maffezzini, M.; Salvioni, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer. (July 2018) Authors: Cavalieri, S.; Perrone, F.; Miceli, R.; Ascierto, P.A.; Locati, L.D.; Bergamini, C.; Granata, R.; Alfieri, S.; Resteghini, C.; Galbiati, D.; Busico, A.; Paielli, N.; Patuzzo, R.; Maurichi, A.; Gallino, G.; Ruggeri, R.; Mariani, L.; Palla, M.; Licitra, L.; Bossi, P. Journal: European journal of cancer Issue: Volume 97(2018) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗